natural pdt, quality Flashcards

1
Q

why is cocaine classified as an alkaloid

A

1 nitrogen atom in an amine ring structure
due to the N found in the ring structure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

pdts from cocaine hydrolysis

A

Basic conditions. Hydrolyse ester linkages
Form benzoic acid + methanol + ecgonine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Soxhlet extraction of cocaine

A
  1. Leaves packed into extraction thimble
  2. Solvent evaporates and condenses into the thimble
    i. Type of solvent used: use diff volatility, polarity
    * methanol— ethanol — chloroform – hexane
    ii. Thimble here also acts like a filter (Very porous)
  3. Solvent extracts the cocaine and drip into solvent flask
    i. Continuous process
  4. ROTATORY EVAPORATION obtains crude cocaine
    i. Under vacuum to pull out solvent. Residue is component (cocaine)
  5. Recrystallization to obtain pure cocaine
    * Test residual in diff acids –> HPLC (purification)
    * Qualify/ identify and quantify compounds found
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

coca plant consists of

A

Majority (40-50%) is cocaine

Tropacocaine, cinnamoylcocaine, methylecognine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

analgesic property of cocaine is due to ___

A
  1. Rapidly absorbed by mucus mem (due to lipophilic grps, promote mem PERMEATION pka 8.6) – most are unionised
    a. Local anesthetic effect
    b. Can be used topical application
  2. Paralyse sensory ends of nerves + block Na ion channels in neuromem
    a. Protonated cocaine is able to inhibit the Na+ channel intracellularly
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

essential functional grps for cocaine MOA analgeisc

A

i. Aromatic carboxylic acid ester
ii. Basic amino grp
iii. Lipophilic hydrocarbon ring

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

SE of cocaine

A

○ Allergic reactions
○ addiction, withdrawal sx
§ euphoric property (leads to dependence and withdrawal)
○ Tissue irritation
○ Poor stability in aq sol.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Structural modifications (improve analgesic/ decr SE) of cocaine

A

1) Benzoyltropine/ Tropacaine = REMOVAL of carboxymethyl COOCH3 ester grp (position 2)
* less addictive SE, good anesthetic property, but low solubility

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

benzocaine discovery

A

2) Benzocaine = simplified ester grp at position 3 + Add -NH2 grp para position of benzene
* lower solubility, less therapeutic effect
*intramolecular H bond, pKa 2.8 (weak acid)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

procaine discovery

A

3) procaine = replace position 3 ETHYL –> 3* amine
* improve solubility (when 3* protonated)
* retain therapeutic effect, less toxic SE (systemic & local)
* shorter DOA, hydrolysed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

discovery of isogramine

A

cocaine –> isogramine

  • Fused heterocycle
  • Tropine (N cycle) –> dimethyl amine (3*)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

discovery of lidocaine

A
  • Open heterocylce, add in O
  • Forms amide functional grp next to phenyl ring
    □ Improves stability (less likely to be hydrolysed)
    □ Dimethyl (CH2 CH3) structure also acts as steric hindrance to block H2O access for hydrolysis
  • Good local anesthetic, less allergenic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

why amide linkage improve stability

A
  • less likely to be hydrolysed (double bond, compared to ester)
  • less likely to be hydrolysed due to dimethyl grps, steric hindrance
  • better solubility (lp on N delocalise into O, forms resonance structure which is charged)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

3 Activity of drugs based on intermediate chain:

A
  • Ester = local anesthetic
  • Amide = local anesthetic
    ○ Longer DOA (more stable, harder to hydrolyse)
  • Amino ETHER, KETONE = rare
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

3 parts of SAR for cocaine-derived local anesthetics

A

1) aromatic part, lipophilic
2) intermediate part (DOA)
3) amino grp, hydrophilic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

1) aromatic part, lipophilic

A
  • Essential for activity – facilitates permeation across neuromem
  • Log P value
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

2) intermediate part (DOA)

A
  • Ester/ amide (followed by 1-3C chain)
  • Determines chemical stability and influence duration of action
    • Amide > ester (more resistant to hydrolysis)
    • But if DOA too long, can reduce LA activity

less common (ketone, ether)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

3) amino grp, hydrophilic

A
  • 2* or 3* amine or N part of heterocycle
  • Basic and ionisable to form cation – affinity to Na+ channel (specific action)
  • Facilitates formulation of INJ
  • pKa of 7.5 - 9
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

ideal Local anesthetic agent

A
  • reversible blockade
  • selective for sensory neuron, no effect on motor neuron
  • rapid onset
  • sufficient DOA
  • chemically stable when sterilised
  • no systemic toxicity
  • wide margin of safety
  • compatible w/ other drugs
  • absence of ADR
  • inexpensive

LA with higher lipid solubility and lower pKa values = faster onset, lower toxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

alkaloids from poppy plant

A
  • Opium is air-dried milky exudate (latex) obtained from capsule of Papaver somniferum
  • Alkaloids found in the latex belong to class of benzyltetrahydroisoquinolone
  • Alkaloids in opium comprise: morphine, codeine, thebaine, papaverine, noscapine, narceine
  • Morphinan: Morphine, codeine, thebaine (diff grp attached to benzyl grp, position 3. elimination reaction to form C=C)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Narcotic analgesic eg

A

1) morphine
2) codeine (most are semi-synthesised)
3) semi-synthesis of morphine derivatives (pholcodine, dihydrocodeine, diamorphine)
4) synthetic (pentazocine, pethidine, fentanyl, alfentanil/ remifentanil, tramadol, methadone)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

pholcodine (from morphine)

A

alkylation w/ N-(chloroethyl)morpholine

  • antitussive
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

dihydrocodeine from morphine/ codeine

A

1) morphine –> codeine (3* O-CH3 instead of OH)
2) reduce C7-8 double bond –>cyclohexane
H2 + catalyste

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

diamorphine/ heroin from morphine

A

esterification of Diacetate of morphine 3-, 6-

  • incr lipophilic = better transport, absorption + ADDICTION
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

narcotic antagonist

A

1) nalbuphine (mixed agonist-antagonist)
2) naloxone (anta > agonist)
3) naltrexone (anta > agonist)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Morphine

A
  • Powerful analgesic and narcotic. Hosp use (risk of resp depression)
  • Unintended SE: Euphoria and mental detachment w/ regular use
  • ADR: constipation, NV, tolerance, withdrawal
  • Metabolised at 2 diff sites
    ○ Glucuronidation at position 3: antagonistic to analgesic effects of morphine
    ○ Glucuronidation at position 6: agonist
    □ More effective and longer lasting analgesic, fewer SE > morphine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Codeine

A
  • 3-O-methyl ether (of morphine) widely used and 1/10 potency of morphine
  • PO. In many analgesic prep (Panadeine = paracetamol 500mg + codeine 8mg)
  • ADR: constipation
  • Unintended SE: non addictive medium analgesic (relatively safe)
  • Indication: antitussives (relieve and prevent cough)
    ○ Depress cough centre, raise the threshold for sensory cough impulses
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Pentazocine

A
  • Morphine-like structure
    ○ Ether bridge omitted
    ○ Cyclohexane ring –> simple methyl grp
  • Good analgesic, non-addictive. But can induce withdrawal sx
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Pethidine

A

○ Less potent than morphine.
○ Produces prompt, short acting analgesia
○ ADR: less constipating than morphine, less resp depression effect (good for outpt use)
○ Unintended SE: addictive
○ Only aromatic ring and piperidine systems retained

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

fentanyl

A
  • 4-phenyl-piperidine structure –> 4-anilino structure
    ○ 50-100x more active > morphine
    □ Higher lipophilicity
    □ Excellent transport properties
    ○ Rapid acting, used in operative procedures
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Alfentanil, remifentanil

A

○ Further variants of fentanyl structure
Rapid acting, used in operative procedures

32
Q

Tramadol

A
  • Produce analgesia by opioid mechanism and by enhancement of 5HT & NE pathways
  • Few typical opioid SE
  • Has 3-methoxy phenyl cyclohexane
33
Q

Methadone

A
  • No longer have: piperidine ring system
    ○ Has diphenylpropylamine derivative that can mimic piperidine ring conformation
  • PO active, similar activity to morphine, longer DOA
  • ADR: less euphorigenic
  • Unintended SE: potentially addictive (as morphine)
    ○ Diff withdrawal sx, less severe
  • Indication: tx and rehabilitation of heroin addicts
34
Q

Narcotic antagonist

A

N-alkyl derivatives related to oxymorphone/ oxycodone

Nalbupine (less SE & abuse potential)

naloxene (heron addicts children, opioid poisoning)
naltrexone (similar activity)

35
Q

QA processes

A

Controls overall methods and procedures at system level
Process oriented. Focus on quality of manufactured pdts
Strictly adhered to

  • external inspection (HSA)
  • Good laboratory practice (GLP)
  • Good manufacturing practice (GMP)
36
Q

QC processes

A

Controls parts in processes that manufacture the pdts
Product orientated. Focus on quality of manufactured pdts

  • batch inspection, pdt sampling
  • internal inspection
37
Q

Good manufacturing processes

A
  • Raw/ starting materials used in manufacturing must be pure
    ○ Pharmacopeia specific. Not contaminated with impurities
  • Premises and equipment used for manufacturing must be maintained for operational readiness
    ○ Premises, walls. Positive P, rounded walls
    ○ People involved: gowns, coverings
    ○ Equipment: run for 24hr.
    § The cleaning also need to follow the guidelines. Procedural & documented SOP
  • People involved in manufacturing process must be trained to competent level
    ○ Weigh properly, proper documentation
  • Manufacturing procedures must use latest technology and science
    ○ New tech need to be verified for use
  • Processes must be documented to show compliance
38
Q

Who overlooks quality for medicines

A

International Conference on Harmonisation of technical Requirements for Registration of Pharmaceuticals for Human Use (ICH)

39
Q

ICH standardises

A
  • Org that standardises the requirements for medicines regulation throughout the world
  • Standardise validation of analytical procedures
  • indicates that validation requried for
    ○ Identification tests
    ○ Quantitative tests for impurities
    ○ Limit tests for control of impurities
    ○ Quantitative tests of API, drug pdt and selected compounds (excipients) in drug pdt
40
Q

Sources of impurities

A
  • Raw materials (contaminants)
  • Method of manufacture
  • atmospheric contaminants
  • manufacturing hazards
  • inadequate storage conditions
41
Q

Method of manufacture

A
  • Reagents employed in process
  • Reagents added to remove other impurities
  • Solvents
    ○ Eg: chloroform. Need to be completely removed, limited amt of residual
  • Reaction vessels (if washed, residual detergent may be left behind)
42
Q

atmospheric contaminants

A
  • CO2 dissolve –> carbonic acids (affect pH)
  • Dust
43
Q

manufacturing hazards

A
  • Particulate contamination
    ○ Esp w/ injection formulation
  • Process errors
  • Cross-contamination
    ○ Cannot use same facilities/ machines to make diff drugs
  • Microbial contamination
    ○ Esp in solutions, syrups (water = growth)
  • Packing errors
44
Q

inadequate storage

A

○ Filth, environment, humidity (hydrolysis)
○ Chemical instability, light exposure
○ Reaction with container materials
○ Physical changes
○ Temp effects

45
Q

Limit tests types and purpose

A
  • Designed to identify and control small qty of impurity which may be present in drug sub
  • May be quantitative or semi

1) comparison (semi-qty)
2) quantitative determination

46
Q

1) comparison (semi-qty)

A

Chlorides, sulphates, iron, heavy metals

1) Standard is set up with definite amt of impurity
- At same time
- Same conditions as test exp
2) Compare test and standard solution
- Turbidity
- No ppt

47
Q

2) Quantitative determinations

A
  • Limits if insoluble matter
  • Limit of soluble matters
  • Limits of moisture, volatile matters, residual solvents
  • Limits of non-volatile matter
  • Loss on ignition
    ○ Limits of residue on ignition
    ○ Ash values
  • Precipitation methods
48
Q

ash test (Qty)

A

Ash test: measure total ash remaining after incineration.
High ash value indicates:
○ Contamination, substitution or carelessness in preparing the crude drugs
○ Presence of inorganic salts of carbonates, phosphates, silicates — Na, K, Ca, mg

1) Incinerate crude drug
2) Weigh the amt of ash after cooled (in a dry environment)
3) Compare weight to pharmacopeia

49
Q

Identification tests eg

A

Monograph of pharmacopeia usually have multiple methods to identify chemical drug sub

1) infrared absorption test
2) UV absorption test
3) TLC (thin layer chromatography) test

50
Q

Infrared absorption test

  • Compare the IR spectrum of test sample & USP reference standard
A
  • MOA: Molecules absorb IR waves, gains energy based on the bonds in diff functional grps in structure
    • Bonds can be bend/ stretched
    • Appear as a peak
      ○ Allows identification of functional grps
    • Has fingerprint region (600-1400 cm-1) of IR spectrum
      ○ Unique to molecule. Can identify molecule if have same absorbent spectrum within this value
51
Q

UV absorption test

  • UV absorption measured of a test sol and standard sol
    • Use 1 cm cell, over 200-400nm
A
  • Compare the UV spectra of test and standard sol
    • Determine the absorptivity and absorbance ratio as indicated in monograph
    • Requirements are met if UV absorption spectra of test and standard sol exhibit maxima and minima at same wavelength
    • Absorptivity and/or absorbance ratios are within specified limits
52
Q

TLC

  • Develop a TLC using silica gel chromatographic plate impregnated with suitable fluorescing sub
  • Apply 10uL test sol and 10uL standard sol (prepared from USP reference standard)
  • Use TLC developing solvent
    • 180:15:1 (chloroform, methanol, water) mixture
A
  • Rf value of principal spot obtained from test sol ~corresponds~ to that from standard sol
    = positive identity to standard reference

Rf = distance travelled by SOLUTE/ SOLVENT

53
Q

quantify purity of analyte by 2 methods

A

1) titrimetric analysis
2) HPLC

54
Q

1) titrimetric analysis eg

A

direct acid/base titration
- argentometric titration

indirect titration
- blank titration

Argentometric titration (direct)
Complexometric titration
Redox titration
Non-aqueous titration
Potentiometric titration

55
Q

1) Titrimetric analysis principles and application

A
  • Principles: the amt of a standard reagent of precisely known conc is used to react chemically with an analyte such that the amt of the standard reagent used can be used to estimate the purity of the analyte
  • Application: Used in pharmacopeia assays to determine the purity of active content of API in a dosage form, purity of raw materials for medicinal pdt prep
56
Q

titrimetric ADV & DISADV

A

ADV:
i. Capable of high degree of precision and accuracy
ii. Methods are generally robust
iii. Analyses can e automated and cheap to perform (esp for countries that may not have suff resources)

DISADV:
i. Method may not be selective
ii. Time-consuming
iii. Require large amts of sample and reagents

57
Q

Indirect titration in aqueous phase mechanism

A

Involve addition (from pipette) an excess of standard volumetric sol (VS) to weighed amt of analyte.

Followed by determination of excess unreacted VS

58
Q

indirect titration used for.

A

1) Volatile sub (NH3, volatile oil)
◊ Evaporates off, not very accurate
◊ Add reagent to prevent sub from evaporating off

2) Insol sub (CaCO3)
3) Sub for which quantitative reaction proceeds rapidly only in excess of a reagent
◊ Excess reagent to make reaction. Back titrate the remaining excess reagent

4) Sub which requires heating with volumetric reagent during determination in which a decomposition / loss of reactants or pdts would occur in the process (aspirin)
◊ Heating can cause other rxn

59
Q

blank titration (also an indirect)

A
  • Blank titration to standardize conditions in both blank and sample determination
  • involve heating a lq containing excess of standard alkali, cooling and back titrate excess
    ◊ Heating and cooling affects strength of excess reagent
    ◊ Need to account for it. So blank and analyte undergo same conditions
60
Q

Argentometric titration (direct)

A
  • Quantitative precipitation used for volumetric determinations, provided the point at which PPT is complete can be determined

NaCl + AgNO3 –> AgCl (ppt) + NaNO3

  • NaCl sol can be determined by: titration with AgNO3 (AgCL ppt)
  • Excess AgNO3 reacts with Potassium Chloromate (indicator – red coloration = end point)
61
Q

Considerations for titration

A
  • primary standards
  • correction factor
62
Q

primary standards

A
  • Stable chemical compounds that are available in high purity
  • Used to standardise the standard sol used in titrations
    • Eg: titrant (NaOH) standardised against Potassium hydrogen phthalate (available in high purity)
    • Use to determine the correction factor (f)
63
Q

correction factor (f)

A
  • Usually used in volumetric analysis to simplify calculations
  • Factor is calculated as a ratio (Actual conc/ Desired, nominal conc)
    * Tells us how much a given sol differs from the nominal/ true conc

f = 1, prep sol is prepared precisely to desired conc
Actual conc = (0.5 N) x 0.96 (factor) = 0.48N

64
Q

f < 1

A

prepared sol is of lower conc than what was desired – usually (absorb water, moisture)

65
Q

f > 1

A

prep sol is of higher conc than what was desired

66
Q

HPLC

A
  • analyses based on calibration with external standard
  • Analyses using calibration against an internal standard
67
Q

external standard
* Put in “x” amt, get “ x” amt
- Plot area under curve and varying conc
- Recovery is complete then can use EXTERNAL standard

A

Analyses based on single point calibration
i. If recovery complete: peak of analyte compared with calibration curve of standard analyte
* When TDM, how much drug present by HPLC – assay with internal standard used
* If cannot retrieve an “x” amt of drug than recovery incomplete, maybe mostly bound to proteins

68
Q

calibration with external standard

A

conc against peak area graph

69
Q

adv of external standard

A
  • used when sample does not interfere with analysis
  • simpler to use
  • does not ened reference standard for every sample
70
Q

disadv of external standard

A
  • relatively accurate if have wider range of concentration used to make calibration curve
  • affected by instrumental performance
71
Q

internal standard

A
  • Should be closely related in structure to analyte
  • Should be stable
  • Should be chromatographically resolved from analyte and excipients present
  • Elute as CLOSE AS POSSIBLE to analyte with restrictions above
    • For given weight should produce a detector response similar to that produced by analyte
    • Same time, but more dissolved peak, not overlap same
72
Q

calibration with internal standard

A

conc of unknown = Peak area of INTERNAL x (peak area ratio unknown)/ (peak area ratio of known)

peak area ratio =
(unknown/ INT standard)
(known/ standard)

73
Q

calibration with internal standard

A

conc of unknown = Peak area of INTERNAL x (peak area ratio unknown)/ (peak area ratio of known)

peak area ratio =
(unknown/ INT standard)
(known/ standard)

74
Q

adv of internal standard

A
  • any variations in sample prep or instrument response are corrected by comparing the peak area / height of the analyte to that of the internal standard
  • more accurate and precise measurement
75
Q

disadv of internal standard

A
  • difficulty selecting appropriate internal standard
  • requires reference standard for every sample
76
Q

why we do internal standard

A

If we want to quantify drug substances from biological fluids

Most methods in pharmacopoeia don’t use internal standards, as already use very ‘clean’ analyte VS biological fluids like blood

E.g., TDM (plasma concentration - biological system) need internal standard to check extraction method